Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 pilot variability study of long-acting filgrastim in healthy volunteers
NL-OMON37064Phase 1Active, not recruiting
- Sponsor
- Mylan
- Start
- Oct 2012
- Modality
- Cytokines & Interferons → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of filgrastim in neutropenia, sponsored by Mylan. Primary endpoints: Pharmacokinetics, Pharmacodynamics and 1 more. Started Oct 2012; status: active, not recruiting.
02
Drugs
filgrastim
03
Conditions
neutropenia
Beyond the preview
Go deeper on NL-OMON37064.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37064.